Reasons for poor uptake of TB preventive therapy in South Africa
Public Health Action · 2022-12 · 12 (4) · 159-164
DOI: 10.5588/pha.22.0030 ↗Kurz gefasst
Fachartikel in der Zeitschrift Public Health Action, online erschienen am 01.12.2022. Verfasst von D P Baloyi und 13 weiteren Autor:innen. Beteiligte Einrichtung: Desmond Tutu TB Centre, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Tygerberg, Sout…. Die Arbeit wurde bisher 43-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: FIC NIH HHS.
Abstract (Originalsprache)
BACKGROUND: South Africa has one the highest TB and HIV burdens globally. TB preventive therapy (TPT) reduces the risk of TB disease and TB-related mortality in adults and children living with HIV and is indicated for use in TB-exposed HIV-negative individuals and children. TPT implementation in South Africa remains suboptimal. METHODS: We conducted a pragmatic review of TPT implementation using multiple data sources, including informant interviews ( n = 134), semi-structured observations ( n = 93) and TB patient folder reviews in 31 health facilities purposively selected across three high TB burden provinces. We used case descriptive analysis and thematic coding to identify barriers and facilitators to TPT implementation. RESULTS: TPT programme implementation was suboptimal, with inadequate monitoring even in health districts with well-functioning TB services. Health workers reported scepticism about TPT effectiveness, deprioritised TPT in practice and expressed divergent opinions about the cadres of staff responsible for implementation. Service- and facility-level barriers included ineffective contact tracing, resource shortages, lack of standardised reporting mechanisms and insufficient patient education on TPT. Patient-level barriers included socio-economic factors. CONCLUSIONS: Improving TPT implementation will require radically simplified and more feasible systems and training for all cadres of health workers. Partnership with communities to stimulate demand driven service uptake can potentially facilitate implementation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Desmond Tutu TB Centre, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Tygerberg, South Africa.
- Department of Psychology, University of KwaZulu-Natal, Durban, South Africa.
- School of Human Sciences, University of Greenwich, London, UK.
- ICAP at Columbia University, Mailman School of Public Health, New York, NY, USA.
- The Aurum Institute, Parktown, Johannesburg, South Africa.
- TB HIV Care, Cape Town, South Africa.
Förderung
- FIC NIH HHS
Zitieren
APA
Baloyi, D. P., Anthony, M. G., Meyerson, K. A., Mazibuko, S., Wademan, D., Viljoen, L., Myburgh, H., du Preez, K., Osman, M., Hirsch-Moverman, Y., Charalambous, S., Hausler, H., Hesseling, A. C., & Hoddinott, G. (2022). Reasons for poor uptake of TB preventive therapy in South Africa. Public Health Action, 12(4), 159-164. https://doi.org/10.5588/pha.22.0030
Vancouver
Baloyi DP, Anthony MG, Meyerson KA, Mazibuko S, Wademan D, Viljoen L, et al. Reasons for poor uptake of TB preventive therapy in South Africa. Public Health Action. 2022;12(4):159-164. doi:10.5588/pha.22.0030
BibTeX
@article{Baloyi2022,
author = {Baloyi, D P and Anthony, M G and Meyerson, K A and Mazibuko, S and Wademan, D and Viljoen, L and Myburgh, H and du Preez, K and Osman, M and Hirsch-Moverman, Y and Charalambous, S and Hausler, H and Hesseling, A C and Hoddinott, G},
title = {Reasons for poor uptake of TB preventive therapy in South Africa},
journal = {Public Health Action},
year = {2022},
volume = {12},
number = {4},
pages = {159--164},
doi = {10.5588/pha.22.0030}
}
EUVIMED